Skip to main content
SpringerLink
Log in

Receptor Physiology in Acute Heart Failure

  • Chapter
Acute Heart Failure

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 6))

  • 93 Accesses

Abstract

Acute heart failure is accompanied by many perturbations in the body’s homeostatic control system. The peripheral systems in the body are dependent on adequate heart function and when cardiac function is disturbed, these peripheral systems fail to function normally. The peripheral vascular system is an excellent example of this disordered response. When the peripheral vascular perfusion pressure falls as a result of cardiac pump failure, the peripheral receptor system interprets the fall to be the result of a decrease in the intravascular volume and initiates a chain of events which result in salt and water retention. This response may be a maladaptive reaction to stress and may worsen an already tenuous situation. The regulation of the peripheral vascular system is under the control of the sympathetic nervous system and in this chapter we examine this system and its derangements in heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Guyton AC (1981) Textbook of medical physiology, 6th edn. Saunders, Philadelphia, p 719

    Google Scholar 

  2. Langer SZ, Shepperson NB (1982) Postjunctional alpha-1 and alpha-2 adrenoceptors: preferential innervation of alpha-1 adrenoceptors and the role of neuronal uptake. J Cardiovasc Pharmacol 4: S8 - S13

    Article  PubMed  Google Scholar 

  3. Langer SZ, Shepperson NB (1982) Recent developments in vascular smooth muscle pharmacology: the postsynaptic alpha-2 adrenoceptor. Trends Pharmacol Sci 3: 440–444

    Article  CAS  Google Scholar 

  4. Pichler L, Kobinger W (1981) Centrally mediated cardiovascular effects of B-HT 920 (6allyl-2-amino-5, 6, 7, 8-tetrahydro-4H-thiozolo-(4, 5-d)-azepine dihydrochloride), a hypotensive agent of the “clonidine type.” J Cardiovasc Pharmacol 3: 269–277

    Article  PubMed  CAS  Google Scholar 

  5. Fitz-Gerald GA, Watkins J, Dollery CT (1981) Regulation of norepinephrine release by peripheral alpha-2 receptor stimulation. Clin Pharmacol Ther 29: 160–167

    Article  CAS  Google Scholar 

  6. Reid JL, Wing LMH, Mathias CJ, Frankel HL, Neill E (1977) The central hypotensive effect of clonidine. Studies in tetraplegic subjects. Clin Pharmacol Ther 21: 375–381

    PubMed  CAS  Google Scholar 

  7. Ruffolo RR Jr, Nichols AJ, Hieble JP (1988) Functions mediated by alpha-2-adrenergic receptors. In Limbird L (ed) The alpha-adrenergic receptors. Humana Press Clifton, NJ (in press)

    Google Scholar 

  8. Onesti G, Schwartz AB, Kim KE (1971) Antihypertensive effect of clonidine. Circ Res 28 (suppl 2): 53–69

    PubMed  Google Scholar 

  9. Timmermans PB, Hoefke W, Stahle W, van Zwieten PA (1980) Structure-activity relationships in clonidine-like imidazolidines and related compounds. Prog Pharmacol 3: 1–104

    Google Scholar 

  10. Barajas L, Wang P (1979) Localization of tritiated norepinephrine in the renal arteriolar nerves. Anat Res 195: 525

    Article  CAS  Google Scholar 

  11. Ruffolo RR Jr (1988) Cardiovascular adrenoceptors: physiology and critical care implications. In: Chernow B, Zaritsy AL, Zaloga GP (eds) The pharmacologic approach to the critically ill patient. Williams & Wilkins Co, Baltimore, pp 166–183

    Google Scholar 

  12. Schmidz JM, Graham KM, Saglowsky A, Pettinger WA (1981) Renal alpha, and alpha2adrenergic receptors: biochemical and pharmacological correlations. J Pharmacol Exp Ther 219: 400–406

    Google Scholar 

  13. Drew GM, Whiting SB (1979) Evidence for two distinct types of postsynaptic alpha adrenoceptors in vascular smooth muscle in vivo. Br J Pharmacol 67: 207–215

    PubMed  CAS  Google Scholar 

  14. Horn PT, Kohli JD, Listinsly JJ, Goldberg LI (1982) Regional variation in the alpha adrenergic receptors in the canine resistance vessels. Naunyn Schmiedeberg’s Arch Pharmacol 318: 166–172

    Article  PubMed  CAS  Google Scholar 

  15. Hesse IFA, Johns EJ (1984) An in vivo study of the alpha adrenergic subtypes on the renal vasculature of the anesthestised rabbit. J Auton Pharmacol 4: 145–152

    Article  PubMed  CAS  Google Scholar 

  16. Gilman AG (1984) Guanine nucleotide regulatory proteins and dual control of adenylate cyclase. J Clin Invest 73: 1–4

    Article  PubMed  CAS  Google Scholar 

  17. Cohn JN, Levine TB, Olivari MM, et al (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive failure. N Engl J Med 311: 819–823

    Article  PubMed  CAS  Google Scholar 

  18. Levine TB, Francis GS, Goldsmith SR (1982) Activity of the sympathetic nervous system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive failure. Am J Cardiol 49: 1659–1666

    Article  PubMed  CAS  Google Scholar 

  19. Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233–243

    Article  PubMed  CAS  Google Scholar 

  20. Chidsey CA, Harrison DC, Braunwald E (1962) Augmentation of plasma norepinephrine response to exercise in patients with congestive heart failure. N Engl J Med 267: 650

    Article  PubMed  CAS  Google Scholar 

  21. Goldstein DS (1981) Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology. Am J Cardiol 48: 1147

    Article  PubMed  CAS  Google Scholar 

  22. Malliani A, Pagani M (1983) The role of the sympathetic nervous system in congestive heart failure. Eur Heart J 4 (Suppl A): 49

    PubMed  Google Scholar 

  23. Bristow MR, Ginsburg R, Minobe W, et al (1982) Decreased catecholamine sensitivity and beta adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205–211

    Article  PubMed  CAS  Google Scholar 

  24. Bristow MR, Laser JA, Minobe W, Ginsburg R, Fowler MB, Rasmussen R (1984) Selective down-regulatin of betas-adrenergic receptors in the failing human heart (abstr.) Circulation 70 (suppl II): 67

    Google Scholar 

  25. Colucci WS, Alexander RW, Williams GH, et al (1981) Decreased lymphocyte beta adrenergic receptor density in patients with heart failure and tolerance to the beta adrenergic agonist pirbuterol. N Engl J Med 305: 185–190

    Article  PubMed  CAS  Google Scholar 

  26. Gordon EP, Bristow MR, Laser JA, Minobe WA, Fowler MB, Savin WM (1983) Correlation between beta adrenergic receptors in human lymphocytes and heart (abstr.) Circulation 68 (suppl III): 99

    Google Scholar 

  27. Baumann G, Mercader D, Busch U, et al (1983) Effects of the H2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease. J Cardiovasc Pharmacol 5: 618–625

    Article  PubMed  CAS  Google Scholar 

  28. Bristow MR (1984) Myocardial beta adrenergic receptor down regulation in heart failure. Int J Cardiol 5: 648–652

    Article  PubMed  CAS  Google Scholar 

  29. Chidsey CA, Braunwald E, Morrow AG (1965) Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am J Med 39: 442–451

    Article  PubMed  CAS  Google Scholar 

  30. Chang HY, Klein RM, Junos G, et al. Selective desensitization of cardiac beta receptors by prolonged in vivo infusion of catecholamines in rats. J Pharmacol Exp Ther 221: 784–789

    Google Scholar 

  31. Weiss RJ, Tobes M, Wertz CE, Smith CB (1983) Platelet alpha2 adrenoceptors in chronic congestive heart failure. Am J Cardiol 52: 101–105

    Article  PubMed  CAS  Google Scholar 

  32. Ruffolo RR Jr, Kopia GA (1986) Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure. Am J Med 80 (Suppl 2B): 67–72

    Article  PubMed  Google Scholar 

  33. Gaffney TE, Braunwald E (1963) Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med 34: 320

    Article  PubMed  CAS  Google Scholar 

  34. Epstein SE, Braunwald E (1966) The effect of beta adrenergic blockade on patterns of urinary sodium excretion: Studies in normal sujects and in patients with heart disease. Ann Intern Med 75: 20

    Google Scholar 

  35. Braunwald E (1984) Pathophysiology of heart failure. In: Braunwald E (ed) Heart disease: A textbook of cardiovascular medicine. Saunders, Philadelphia, pp 447–466

    Google Scholar 

  36. Higgins CB, Vatner SF, Franklin D, Braunwald E (1972) Effects of experimentally produced heart failure on the peripheral vascular response to severe exercise in conscious dogs. Circ Res 31: 186

    PubMed  CAS  Google Scholar 

  37. Vanhoutte PM (1983) Adjustments in the peripheral circulation in chronic heart failure. Eur Heart J 4 (Suppl A): 186

    Google Scholar 

  38. Grassi G, Giannattasio C, Cuspidi C, et al (1988) Cardiopulmonary receptor regulation of renin release. Am J Med 84 (suppl 3A): 97–104

    Article  PubMed  CAS  Google Scholar 

  39. Abboud FM, Thames MC, Mark AL (1981) Role of cardiac afferent nerves in regulation of circulation during coronary occlusion and heart failure. In: Abboud FM, Fozzard HA, Gilmore JP, Reis DJ (eds) Disturbances in neurogenic control of the circulation. Bethesda, MD: American Physiological Society, p 65

    Google Scholar 

  40. Belleau L, Mion H, Simard S, et al (1970) Studies on the mechanism of experimental congestive heart failure in dogs. Can J Physiol Pharmacol 48: 450

    Article  PubMed  CAS  Google Scholar 

  41. Zehr JE, Hawe A, Tsakiris AG, Rastelli GC, McGoon DC, Segar WE (1971) ADH levels following nonhypotensive hemorrhage in dogs with chronic mitral stenosis. Am J Physiol 221: 312

    PubMed  CAS  Google Scholar 

  42. Mancini DM, Le Jemtel TH, Factor S, Sonnenblick EH (1986) Central and peripheral components of cardiac failure. Am J Med 80 (Suppl 2B): 2–13

    Article  PubMed  CAS  Google Scholar 

  43. Newman WH (1978) Volume overload heart failure: length-tension curves, and response to beta-agonists, Ca’, and glucagon. Am J Physiol 235: H690 - H700

    PubMed  CAS  Google Scholar 

  44. Chernow B, Reed L, Geelhoed GW, et al (1986) Glucagon: Endocrine effects and calcium involvement in cardiovascular actions in dogs. Circ Shock 19: 393–407

    PubMed  CAS  Google Scholar 

  45. Chernow B, Zaloga GP, Malcolm D, et al (1987) Glucagon’s chronotropic action is calcium dependent. J Pharm Exp Ther 241: 833–837

    CAS  Google Scholar 

  46. Zaloga GP, Willey S, Malcolm D, Chernow B, Holaday J (1988) Hypercalcemia attenuates the blood pressure response to epinephrine. J Pharm Exp Ther (in press)

    Google Scholar 

  47. Chernow B, Zaloga GP, McFadden E, et al (1982) Hypocalcemia in critically ill patients. Crit Care Med 10: 848–851

    Article  PubMed  CAS  Google Scholar 

  48. Zaloga GP, Chernow B (1987) The multifactorial basis for hypocalcemia during sepsis. Ann Intern Med 107: 36–41

    PubMed  CAS  Google Scholar 

  49. Zaloga GP, Willey S, Tomasic P, Chernow B (1987) Free fatty acids alter calcium binding: A cause for misinterpretation of serum calcium values and hypocalcemia in critical illness. J Clin Endocrinol Metab 64: 1010–1014

    Article  PubMed  CAS  Google Scholar 

  50. Zaritsky AL, Chernow B (1983) Catecholamines, sympathomimetics. In: Chernow B, Lake CR (eds) The pharmacologic approach to the critically ill patient. Williams & Watkins, Baltimore

    Google Scholar 

Download references

Authors
  1. G. G. Stanford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Chernow
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, C. H. U. Vaudois, CH-1011, Lausanne, Switzerland

    Claude Perret (Director) (Director)

  2. Department of Intensive Care, Erasme University Hospital, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean Louis Vincent (Assistant-Director) (Assistant-Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stanford, G.G., Chernow, B. (1988). Receptor Physiology in Acute Heart Failure. In: Perret, C., Vincent, J.L. (eds) Acute Heart Failure. Update in Intensive Care and Emergency Medicine, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83453-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83453-0_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19169-8

  • Online ISBN: 978-3-642-83453-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation